Stocks and Investing
Stocks and Investing
Fri, December 15, 2023
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Ami Fadia Maintained (BCYC) at Strong Buy with Decreased Target to $43 on, Dec 15th, 2023
Ami Fadia of Needham, Maintained "Bicycle Therapeutics plc" (BCYC) at Strong Buy with Decreased Target from $46 to $43 on, Dec 15th, 2023.
Ami has made no other calls on BCYC in the last 4 months.
There are 4 other peers that have a rating on BCYC. Out of the 4 peers that are also analyzing BCYC, 1 agrees with Ami's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Jeffrey Hung of "Morgan Stanley" Maintained at Hold with Decreased Target to $40 on, Friday, November 3rd, 2023
These are the ratings of the 3 analyists that currently disagree with Ami
- Li Watsek of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $65 on, Wednesday, November 8th, 2023
- Kalpit Patel of "B. Riley Securities" Upgraded from Hold to Strong Buy and Held Target at $33 on, Tuesday, September 12th, 2023
- Reni Benjamin of "JMP Securities" Reiterated at Buy and Held Target at $44 on, Tuesday, September 12th, 2023
Contributing Sources